168 related articles for article (PubMed ID: 38591109)
1. Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.
Kim D; Kim S; Song H; Gwak D; Min S; Byun JM; Koh Y; Hong J; Yoon SS; Yun H; Shin DY
Cancer Med; 2024 Apr; 13(7):e7182. PubMed ID: 38591109
[TBL] [Abstract][Full Text] [Related]
2. Clonal evolution of acute leukemia genomes.
Jan M; Majeti R
Oncogene; 2013 Jan; 32(2):135-40. PubMed ID: 22349821
[TBL] [Abstract][Full Text] [Related]
3. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
4. [Detection of heterogeneity and evolution of subclones in t(8;21) AML by QM-FISH].
Wang YC; Hu LP; Lin D; Li CW; Yuan T; Jia YJ; Tian Z; Tang KJ; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2013 Oct; 34(10):844-50. PubMed ID: 24171957
[TBL] [Abstract][Full Text] [Related]
5. Convergent epigenetic evolution drives relapse in acute myeloid leukemia.
Nuno K; Azizi A; Koehnke T; Lareau C; Ediriwickrema A; Corces MR; Satpathy AT; Majeti R
Elife; 2024 Apr; 13():. PubMed ID: 38647535
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clonal architecture between primary and immunodeficient mouse-engrafted acute myeloid leukemia cells.
Kawashima N; Ishikawa Y; Kim JH; Ushijima Y; Akashi A; Yamaguchi Y; Hattori H; Nakashima M; Ikeno S; Kihara R; Nishiyama T; Morishita T; Watamoto K; Ozawa Y; Kitamura K; Kiyoi H
Nat Commun; 2022 Mar; 13(1):1624. PubMed ID: 35338146
[TBL] [Abstract][Full Text] [Related]
7. Cytokines can reduce clonal, CD34-positive cells in acute myeloid leukemia in vitro.
Braun S; Gerhartz HH; Schmetzer HM
Ann Hematol; 2000 Jul; 79(7):363-73. PubMed ID: 10965784
[TBL] [Abstract][Full Text] [Related]
8. Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression.
Kim T; Yoshida K; Kim YK; Tyndel MS; Park HJ; Choi SH; Ahn JS; Jung SH; Yang DH; Lee JJ; Kim HJ; Kong G; Ogawa S; Zhang Z; Kim HJ; Kim DD
Leukemia; 2016 Feb; 30(2):295-302. PubMed ID: 26424407
[TBL] [Abstract][Full Text] [Related]
9. Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Laczika K; Mitterbauer G; Mitterbauer M; Knöbl P; Schwarzinger I; Greinix HT; Rabitsch W; Fonatsch C; Mannhalter C; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(5):923-31. PubMed ID: 11697647
[TBL] [Abstract][Full Text] [Related]
10. Persistence of pre-leukemic clones during first remission and risk of relapse in acute myeloid leukemia.
Rothenberg-Thurley M; Amler S; Goerlich D; Köhnke T; Konstandin NP; Schneider S; Sauerland MC; Herold T; Hubmann M; Ksienzyk B; Zellmeier E; Bohlander SK; Subklewe M; Faldum A; Hiddemann W; Braess J; Spiekermann K; Metzeler KH
Leukemia; 2018 Jul; 32(7):1598-1608. PubMed ID: 29472724
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.
San Miguel JF; Martínez A; Macedo A; Vidriales MB; López-Berges C; González M; Caballero D; García-Marcos MA; Ramos F; Fernández-Calvo J; Calmuntia MJ; Diaz-Mediavilla J; Orfao A
Blood; 1997 Sep; 90(6):2465-70. PubMed ID: 9310499
[TBL] [Abstract][Full Text] [Related]
12. Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease.
Chao MP; Gentles AJ; Chatterjee S; Lan F; Reinisch A; Corces MR; Xavy S; Shen J; Haag D; Chanda S; Sinha R; Morganti RM; Nishimura T; Ameen M; Wu H; Wernig M; Wu JC; Majeti R
Cell Stem Cell; 2017 Mar; 20(3):329-344.e7. PubMed ID: 28089908
[TBL] [Abstract][Full Text] [Related]
13. Clinical utility of bone marrow culture.
Moore MA
Hamatol Bluttransfus; 1976; 19():79-90. PubMed ID: 795748
[TBL] [Abstract][Full Text] [Related]
14. Subclonal patterns in follow-up of acute myeloid leukemia combining whole exome sequencing and ultrasensitive IBSAFE digital droplet analysis.
Pettersson L; Chen Y; George AM; Rigo R; Lazarevic V; Juliusson G; Saal LH; Ehinger M
Leuk Lymphoma; 2020 Sep; 61(9):2168-2179. PubMed ID: 32425124
[TBL] [Abstract][Full Text] [Related]
15. Clonal heterogeneity as detected by metaphase karyotyping is an indicator of poor prognosis in acute myeloid leukemia.
Bochtler T; Stölzel F; Heilig CE; Kunz C; Mohr B; Jauch A; Janssen JW; Kramer M; Benner A; Bornhäuser M; Ho AD; Ehninger G; Schaich M; Krämer A
J Clin Oncol; 2013 Nov; 31(31):3898-905. PubMed ID: 24062393
[TBL] [Abstract][Full Text] [Related]
16. Clonal architecture of secondary acute myeloid leukemia.
Walter MJ; Shen D; Ding L; Shao J; Koboldt DC; Chen K; Larson DE; McLellan MD; Dooling D; Abbott R; Fulton R; Magrini V; Schmidt H; Kalicki-Veizer J; O'Laughlin M; Fan X; Grillot M; Witowski S; Heath S; Frater JL; Eades W; Tomasson M; Westervelt P; DiPersio JF; Link DC; Mardis ER; Ley TJ; Wilson RK; Graubert TA
N Engl J Med; 2012 Mar; 366(12):1090-8. PubMed ID: 22417201
[TBL] [Abstract][Full Text] [Related]
17. Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity.
Mopin A; Leprêtre F; Sebda S; Villenet C; Ben Khoud M; Figeac M; Quesnel B; Brinster C
PLoS One; 2022; 17(4):e0267508. PubMed ID: 35486629
[TBL] [Abstract][Full Text] [Related]
18. Clonal evolution of acute myeloid leukemia from diagnosis to relapse.
Vosberg S; Greif PA
Genes Chromosomes Cancer; 2019 Dec; 58(12):839-849. PubMed ID: 31478278
[TBL] [Abstract][Full Text] [Related]
19. Single-cell mutational profiling enhances the clinical evaluation of AML MRD.
Ediriwickrema A; Aleshin A; Reiter JG; Corces MR; Köhnke T; Stafford M; Liedtke M; Medeiros BC; Majeti R
Blood Adv; 2020 Mar; 4(5):943-952. PubMed ID: 32150611
[TBL] [Abstract][Full Text] [Related]
20. Molecular and genetic alterations associated with therapy resistance and relapse of acute myeloid leukemia.
Hackl H; Astanina K; Wieser R
J Hematol Oncol; 2017 Feb; 10(1):51. PubMed ID: 28219393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]